Perinatal characteristics prior to first enrolment
|
Variable | Groups | |
| 1% CHG-aq (n=158) | 2% CHG-aq (n=150) | |
| Perinatal characteristics | ||
| Antenatal steroid coverage (n/N)* | 58/67 (86.6) | 45/56 (80.4) |
| Prolonged rupture of membranes, n (%) | 9 (5.7) | 7 (4.7) |
| Meconium-stained liquor, n (%) | 14 (8.9) | 10 (6.7) |
| Born by caesarean section, n (%) | 95 (60.1) | 76 (50.7) |
| Placenta culture positivity, n (%) | 2 (1.3) | 3 (2) |
| High vaginal swab positivity, n (%) | 3 (1.9) | 2 (1.3) |
| Gestation at birth in weeks, median (IQR) | 34 (31–37) | 35 (32–37) |
| Strata 1 (260/7 to 276/7 weeks), n (%) | 2 (1.3) | 4 (2.7) |
| Strata 2 (280/7 to 346/7 weeks), n (%) | 77 (48.7) | 70 (46.7) |
| Strata 3 (350/7 to 416/7 weeks), n (%) | 79 (50) | 76 (50.6) |
| Birth weight in grams (mean±SD) | 2018±759 | 2029±769 |
| <1000, n (%) | 9 (5.7) | 12 (8) |
| 1001–1500, n (%) | 34 (21.5) | 25 (16.6) |
| 1501–2500, n (%) | 66 (41.8) | 73 (48.7) |
| >2501, n (%) | 49 (31) | 40 (26.7) |
| Male gender, n (%) | 88 (55.7) | 87 (58) |
| Intrauterine growth status, n (%) | ||
| Small for gestational age | 33 (20.9) | 39 (26) |
| Appropriate for gestational age | 115 (72.8) | 100 (66.7) |
| Large for gestational age | 10 (6.3) | 11 (7.3) |
| Apgar at 1 min, median (IQR) | 8 (7–9) | 8 (6–9) |
| Apgar at 5 min, median (IQR) | 9 (8–9) | 9 (8–9) |
| Proportion of outborn neonates, n (%) | 36 (22.8) | 32 (21.3) |
*Eligible population for antenatal steroid coverage was between gestation age 260/6 to 336/7 weeks.